Skip to content
MedsAcross

Medicine

Bupropion 200 mg extended-release tablet

Bupropion · Oral
Available on requestPrescription onlyUS FDAGeneric name

Bupropion 200 mg extended-release tablet is a generic prescription medicine for oral use, made by 17 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store at 20° to 25°C (68° to 77°F).

Key facts

Active ingredient (INN)
Bupropion
Brand
Sold under the generic name
Strength
200 mg
Dosage form
Extended-release tablet
Route
Oral
Packs
60 tablets, 100 tablets, 500 tablets and 72 more
Manufacturers
Camber PharmaceuticalsIndiaCiplaIndiaGranules IndiaIndiaAurobindo PharmaIndiaDr. Reddy's LaboratoriesIndiaMacleods PharmaceuticalsIndiaEpic PharmaScieGen PharmaceuticalsSolco HealthcareBryant Ranch Prepack17 labelers on the register
Origin register
US FDA, United States
Storage
Store at 20° to 25°C (68° to 77°F).
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
ATC code
N06AX12 Bupropion
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
3 December 2004
Identifiers
RxCUI 993536, 993503, 993518DailyMed set ID 634bc654-be95-4fea-b308-eed53269a112, 092da413-ec60-4577-ac57-51e3e42d55c9, 6948f63b-599c-4956-a249-e9544beda9fc +21NDC 71335-1870, 50228-176, 43598-538 +21Application ANDA211347, ANDA205794, ANDA090325 +10

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

A sample of 40 packs from 17 labelers. The register lists 75 packs for this generic presentation, and we confirm the exact pack on the quote.

PackCodeLabelerMarketed since
60 tablet, film coated, extended release in 1 bottle, plastic43598-538-60Dr. Reddy's LaboratoriesIndia1 August 2016
60 tablet, film coated, extended release in 1 bottle, plastic43598-753-60Dr. Reddy's LaboratoriesIndia15 May 2018
100 tablet, film coated, extended release in 1 bottle59651-848-01Aurobindo PharmaIndia3 June 2025
60 tablet, film coated, extended release in 1 bottle59651-848-60Aurobindo PharmaIndia3 June 2025
100 tablet, extended release in 1 bottle31722-068-01Camber PharmaceuticalsIndia31 May 2023
500 tablet, extended release in 1 bottle31722-068-05Camber PharmaceuticalsIndia31 May 2023
60 tablet, extended release in 1 bottle31722-068-60Camber PharmaceuticalsIndia31 May 2023
90 tablet, extended release in 1 bottle31722-068-90Camber PharmaceuticalsIndia31 May 2023
30 tablet, extended release in 1 bottle69097-879-02CiplaIndia25 July 2016
60 tablet, extended release in 1 bottle69097-879-03CiplaIndia25 July 2016
100 tablet, extended release in 1 bottle69097-879-07CiplaIndia25 July 2016
500 tablet, extended release in 1 bottle69097-879-12CiplaIndia25 July 2016
30 tablet, film coated, extended release in 1 bottle70010-127-03Granules IndiaIndia31 March 2025
500 tablet, film coated, extended release in 1 bottle70010-127-05Granules IndiaIndia31 March 2025
60 tablet, film coated, extended release in 1 bottle70010-127-06Granules IndiaIndia31 March 2025
60 tablet, extended release in 1 bottle33342-528-09Macleods PharmaceuticalsIndia23 June 2026
100 tablet, extended release in 1 bottle33342-528-11Macleods PharmaceuticalsIndia23 June 2026
60 tablet, extended release in 1 bottle42806-411-60Epic Pharma15 December 2021
100 tablet, extended release in 1 bottle42806-426-01Epic Pharma18 September 2023
500 tablet, extended release in 1 bottle42806-426-05Epic Pharma18 September 2023
60 tablet, extended release in 1 bottle42806-426-60Epic Pharma18 September 2023
100 tablet, extended release in 1 bottle42806-443-01Epic Pharma30 September 2026
60 tablet, extended release in 1 bottle42806-443-60Epic Pharma30 September 2026
60 tablet, film coated, extended release in 1 bottle, plastic0591-3542-60Actavis Pharma2 July 2009
60 tablet, film coated, extended release in 1 bottle0115-5445-13Amneal Pharmaceuticals of New York3 December 2004
60 tablet, film coated, extended release in 1 bottle, plastic77771-176-60Radha Pharmaceuticals15 April 2021
100 tablet, film coated, extended release in 1 bottle, plastic50228-176-01ScieGen Pharmaceuticals20 April 2018
1000 tablet, film coated, extended release in 1 bottle, plastic50228-176-10ScieGen Pharmaceuticals20 April 2018
30 tablet, film coated, extended release in 1 bottle, plastic50228-176-30ScieGen Pharmaceuticals20 April 2018
60 tablet, film coated, extended release in 1 bottle, plastic50228-176-60ScieGen Pharmaceuticals20 April 2018
100 tablet, extended release in 1 bottle70436-060-01Slate Run Pharmaceuticals2 November 2020
500 tablet, extended release in 1 bottle70436-060-02Slate Run Pharmaceuticals2 November 2020
60 tablet, extended release in 1 bottle70436-060-05Slate Run Pharmaceuticals2 November 2020
60 tablet, film coated, extended release in 1 bottle43547-290-06Solco Healthcare1 November 2014
90 tablet, film coated, extended release in 1 bottle43547-290-09Solco Healthcare1 November 2014
100 tablet, film coated, extended release in 1 bottle43547-290-10Solco Healthcare1 November 2014
500 tablet, film coated, extended release in 1 bottle43547-290-50Solco Healthcare1 November 2014
60 tablet, extended release in 1 bottle71335-0801-1Bryant Ranch Prepack1 May 2018
180 tablet, extended release in 1 bottle71335-0801-2Bryant Ranch Prepack9 August 2024
30 tablet, extended release in 1 bottle71335-0801-3Bryant Ranch Prepack9 August 2024

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 30 December 1985Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Other strengths and forms of Bupropion

Clinical summary

Bupropion is an aminoketone indicated for the treatment of major depressive disorder (MDD), as defined by the Diagnostic and Statistical Manual (DSM). It is available as extended-release tablets and tablets for oral use. MedsAcross supplies Bupropion for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Bupropion

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Bupropion 200 mg extended-release tablet for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.